Related Experiment Video
Updated: Nov 25, 2025

Author Spotlight: Establishment and Confirmation of a Postnatal Right Ventricular Volume Overload Mouse Model
Published on: June 9, 2023
Neonatal Heart Responds to Pressure Overload With Differential Alterations in Various Cardiomyocyte Maturation
Xiaoning Ding1, Shoubao Wang2, Ye Wang1
1Shanghai Children's Medical Center, Pediatric Translational Medicine Institute and Shanghai Pediatric Congenital Heart Disease Institute, Shanghai Jiao Tong University School of Medicine, Shanghai, China.
Insights
Neonatal hearts adapt to pressure overload by increasing cardiomyocyte division and growth. This study reveals how the neonatal heart
Area of Science:
- Cardiovascular Biology
- Neonatal Physiology
- Congenital Heart Disease Research
Background:
- Right-sided congenital heart disease (CHD) often involves pressure overload from birth.
- The neonatal heart's response to pressure overload is not well understood.
- Previous work established a pulmonary artery banding (PAB) model in neonatal rats.
Purpose of the Study:
- To investigate the neonatal heart's reaction to pressure overload.
- To understand cardiomyocyte proliferation and maturation under stress.
- To explore the molecular mechanisms driving cardiac adaptation.
Main Methods:
- Utilized a pulmonary artery banding (PAB) model in neonatal rats.
- Employed cardiomyocyte-specific lineage tracing.
- Conducted transcriptomic analyses to assess gene expression profiles.
Main Results:
- PAB accelerated the transition of mononuclear to multinucleated cardiomyocytes, promoting hypertrophy.
- Elevated pressure overload increased cardiomyocyte mitotic activity and cytokinetic markers.
- Transcriptomic data revealed a bivalent expression profile indicating concurrent hypertrophy and immature cardiomyocyte characteristics.
Conclusions:
- Neonatal cardiomyocytes exhibit plasticity, adapting to pressure overload through hypertrophy and hyperplasia.
- Pressure overload differentially impacts cardiomyocyte maturation programs.
- The neonatal heart's response highlights potential therapeutic targets for CHD.
Abstract:
Pressure overload is one of the pathophysiological conditions commonly associated with right-sided congenital heart disease (CHD). Patients suffer from this condition right after birth. However, little is known about how neonatal heart reacts to it. We have previously established a pulmonary artery banding (PAB) model in neonatal rat. Here we show that PAB accelerated transition of mononuclear cardiomyocytes into multinucleated cells to promote hypertrophic growth in neonatal heart. The elevated afterload significantly increased the mitotic activities of neonatal cardiomyocytes. Consistent with the proliferative potential, the elevated pressure overload also increased cytokinetic marker counts of cardiomyocytes. Using cardiomyocyte-specific lineage tracing, we noticed a clonal expansion of rare unlabeled cardiomyocytes in the PAB group, revealing a subgroup of cardiomyocytes with a strong capability of proliferation. In addition, PAB hearts at post-banding day 7 didn't have the accumulation of macrophages, which is an immune response essential for neonatal heart regeneration in injury models. Transcriptomic analyses revealed that neonatal PAB induced an expression profile featuring both cardiomyocyte hypertrophy, such as highly activated translation, oxidative phosphorylation, and mitochondrial biogenesis programs etc., and immature cardiomyocyte, such as enhanced cell cycle activities and glycolytic metabolism, down-regulated cytoskeleton and ion channel gene expression, and maintenance of fetal-specific sarcomeric isoforms etc. It indicates that pressure overload has differential impacts on various cardiomyocyte maturation (CM) programs that may contribute to the concurrent cardiomyocyte hypertrophy and hyperplasia. The bivalent status of transcriptional profile highlights the plasticity of neonatal cardiomyocytes that can be exploited to adapt the postnatal environment.
Related Concept Videos
Heart Failure II: Pathophysiology
Pathophysiology of Heart Failure
Cardiomyopathy III: Hypertrophic Cardiomyopathy

